A total of 322 stool specimens were collected from children with diarrhea who were hospitalized in 3 hospitals from October 2005 through September 2006 in Wuhan. Collection procedures were in accordance with rotavirus surveillance protocols recommended by the World Health Organization. Viral RNA was extracted from stool specimens with the guanidine isothiocyanate method as described (5). Rotavirus electropherotypes were determined by polyacrylamide gel electrophoresis according to the method described by Herring et al. (6). The purified RNAs were examined by reverse transcription–PCR (RT–PCR) using the group A rotavirus–specific primers (Beg9/End9 and Con2/Con3) and then subjected to G genotype typing and P genotype typing by using a heminested RT–PCR strategy and electropherotyping (5,7). The result of G–P typing was confirmed by sequencing 10% of the total samples that were drawn randomly. Sequences of the RT–PCR products were analyzed with the Sequencher program (Gene Codes Corporation, Inc., Ann Arbor, MI, USA) and subsequently compared with the vp7 gene sequences of 11 G9 strains from the GenBank database using E-ClustalW (http://align.genome.jp); the phylogenetic tree was built by Molecular Evolutionary Genetics Analysis (MEGA) version 3.1 program (www.megasoftware.net).

Of 322 stool specimens, human group A rotavirus was detected in 101 (31.4%) case-patients. G typing of the 101 strains identified 67 as G3 (66.3%), 19 as G1 (18.8%), 8 as G1 and G3 mixed infection (7.9%), 4 as untypeable (4%), 1 as G4 (1%), and 2 as G9 (2%). Both rotavirus G and P types could be established in 91 strains, and 6 different combinations were identified (Table 1). G3P[8] (62.6%) was the most common combination detected, followed by G1P[8] (17.6%), G1/G3P[8] (8.8%), G3P[4] (6.6%), G1P[4] (2.2%), and G9P[8] (2.2%).

Figure 1

Figure 1. Polyacrylamide gel electrophoresis of rotavirus RNA. The viral RNAs were analyzed by electrophoresis in a polyacrylamide gel and visualized by silver staining. A, negative control; B, Wuhan G9 strain (CC589).

Figure 2

Figure 2. Phylogenetic analysis of the nucleotide sequences of the vp7 gene of G9 strain isolated in Wuhan and G9 strains from different parts of the world. The bar indicates the variation scale....

Two group A rotavirus strains were designated to G9 genotype by electropherotypes (Figure 1) and RT–PCR. The complete nucleotide sequence and deduced amino acid sequence of the vp7 gene from the Wuhan G9 strain were compared with the vp7 gene sequences of 11 G9 strains from the GenBank database (Table 2). The comparison showed clearly that the vp7 of the Wuhan G9 isolate was closely related to the 2 G9 strains (XJ99–468, XJ04–652) isolated from XinJiang province in China (98.3%–98.4% identity on nucleotide sequence and 97.2%–97.5% similarity on amino acid sequence). Phylogenetic analysis also confirmed that the vp7 gene of the Wuhan G9 strain (CC597, Wuhan, China) clustered in the same branch with those of the XJ99–468 and XJ04–652 G9 strains (Figure 2).

In this study, we presented the distribution of group A rotavirus genotypes and the emergence of the novel G9 genotype of rotavirus in Wuhan City from October 2005 through September 2006. Comparison with the results of the surveillance from 2000 to 2005 in Wuhan showed that the G3P[8] genotype remains the most predominant. Our results are similar to those reported by Fang et al (8), indicating that G3P[8] serotype was the most common strain throughout China from 2001 through 2003.

An important result of this study was the first characterization of the G9 strain isolated from Wuhan during the rotavirus season 2005–2006. Sequence analysis of the vp7 gene of the Wuhan G9 isolate showed that it had high similarity (97.5% amino acid identity) to that of the XJ04–652 strain, which was isolated from the specimen of a 9-day-old infant girl in XinJiang province, China, in December 2004 (Table 2). In the past decade, the number of countries that have reported the detection of rotavirus G9 strains has increased dramatically. Apparently G9 rotaviruses are expanding on a global scale; currently, the G9 serotype is considered to be the fifth most common type worldwide. In Australia, although the serotype G9 was identified for the first time in the 1999–2000 season, a retrospective analysis showed the presence of 3 G9 isolates in the country. During the 1999–2000 and 2000–2001 seasons, it rocketed to the second most common G type and was responsible for 10% and 18.1% of the total group A rotavirus infections in the country, respectively (9). In the 2001–2002 season, the G9 serotype was the most important infecting rotavirus serotype in the country, representing 40.4% of the isolates (10). In Spain, previous studies had identified G1P[8] and G4P[8] as the predominant cocirculating strains from 1995 through 2004. However, these serotypes were displaced by G9P[8] during the 2005 season, when G9P[8] accounted for 50.6% of typed isolates in several regions of Spain (11). Similarly, G9 serotype was identified as the prevailing serotype in several Japanese cities from 1998 to 2000 with high prevalence rates of 52.9% to 71.4% (12). In 1995, the rotavirus G9P[8] emerged in Bangladesh and became the second predominant strain (27.7%) during the 2001–2005 rotavirus seasons (13); G9P[8] accounted for most (91.6%) circulating rotavirus strains in Thailand during the 2000–2001 season and has now become the most common genotype (14). In China, G9 strains were identified in 3 regions including Kunming, Lanzhou, and Qinhuangdao in 1999 and 2003 (8,15); only 1 strain was detected between 1982 and 1997 in Beijing (8). The incidence of G9 genotype increased from 0.9% to 4% from 1999 through July 2003, which coincided with an increased global incidence of G9 strain in various countries. However, it remains a mystery why G9 strain has only now been detected at low frequency in China because it has been one of the most prevalence rotavirus types worldwide for more than a decade.

Since the rotavirus G9 strain is the most widespread emerging rotavirus serotype globally, continued surveillance of rotavirus infections in China is imperative. Surveillance programs can effectively monitor whether G9 rotavirus strains will rise in prevalence. This information will be crucial for the development and evaluation of more efficient vaccines.